Growth Metrics

Cytokinetics (CYTK) Change in Acquisitions & Divestments (2016 - 2025)

Cytokinetics (CYTK) has disclosed Change in Acquisitions & Divestments for 16 consecutive years, with $592.7 million as the latest value for Q4 2025.

  • Quarterly Change in Acquisitions & Divestments changed N/A to $592.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 billion through Dec 2025, changed N/A year-over-year, with the annual reading at $1.1 billion for FY2025, N/A changed from the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 was $592.7 million at Cytokinetics, up from $275.7 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $592.7 million in Q4 2025, with the low at -$530.2 million in Q3 2023.
  • Average Change in Acquisitions & Divestments over 5 years is $117.2 million, with a median of $157.6 million recorded in 2022.
  • The sharpest move saw Change in Acquisitions & Divestments crashed 10647.4% in 2021, then surged 3422.12% in 2024.
  • Over 5 years, Change in Acquisitions & Divestments stood at -$322.9 million in 2021, then soared by 148.82% to $157.6 million in 2022, then plummeted by 100.0% to -$2000.0 in 2023, then skyrocketed by 8502550.0% to $170.0 million in 2024, then surged by 248.55% to $592.7 million in 2025.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $592.7 million, $275.7 million, and $170.0 million for Q4 2025, Q1 2025, and Q3 2024 respectively.